Esaote launches AU5 Harmonic scanner
Italian vendor Esaote released its AU5 Harmonic ultrasound scanner at the Congress of the World Federation for Ultrasound Medicine and Biology in Buenos Aires, Argentina, earlier this month. In its standard configuration, the multidisciplinary scanner
Italian vendor Esaote released its AU5 Harmonic ultrasound scanner at the Congress of the World Federation for Ultrasound Medicine and Biology in Buenos Aires, Argentina, earlier this month. In its standard configuration, the multidisciplinary scanner allows users to optimize ultrasound studies via the use of a contrast agent, according to the Genoa-based company.
AU5 includes both color and power Doppler functions and can accommodate specialized probes, such as high-frequency probes up to 20 MHz, for superficial imaging as well as transducers targeted to intraoperative and surgical applications. It also offers networking capabilities that allow the user to send images and patient data through both a local area network and the Internet, according to Esaote.
The scanner appears to be the enhanced version of Esaote's AU4 system that the vendor has been working on with Bracco (SCAN 7/17/96). According to Esaote, the scanner's dedicated hardware and software that can utilize the second-harmonic imaging method are the first results of an ultrasound contrast research program established by Esaote in cooperation with Bracco.
AU5 is available for sale in international markets except for the U.S., where Esaote expects to be able to sell the scanner next year. The scanner is CE marked, according to Esaote.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
